Sorcero - Fall Seasonal Product Update

At Sorcero, we're on a mission to transform how Life Sciences commercialization teams engage with their key stakeholders - from physicians and regulators to payers and patients. We do this by empowering teams with critical, real-time intelligence and personalized recommendations, streamlining workflows and saving countless hours of manual work.

In our latest release, we’re excited to introduce Sorcero Safety™, a new solution to help safety teams meet critical post-market surveillance needs. We’re also adding new ways for teams to surface actionable insights that can optimize medical strategy and inform KOL engagement.

Introducing Sorcero Safety in partnership with Springer Nature

Stay on top of literature monitoring for post-market surveillance, and quickly take action on publications that require ICSRs.

The need: monitoring safety signals with speed and accuracy

Pharmacovigilance (PV) and medical safety teams play a critical role monitoring product safety by conducting post-market surveillance (PMS). One key part of PMS is the continuous monitoring of global literature for potential safety events and deciding whether an Individual Case Safety Report (ICSR) or other report needs to be filed. Despite dedicating hundreds of hours monthly to this task, teams struggle to keep pace with the more than 2 million articles published annually. In addition, strict US and EU regulatory requirements mandate companies to report safety events in under two weeks. If they fail to do so, they can suffer damage to their reputation, loss of revenue, or even substantial fines.

In order to keep up with these tight but necessary regulations and timeframes, pharmacovigilance teams need a faster, more scalable way to monitor literature.

Introducing Sorcero Safety

Sorcero and Springer Nature have partnered to introduce Sorcero Safety, which revolutionizes literature monitoring for PMS with the industry's most comprehensive literature database for pharmacovigilance and safety teams. This innovative platform streamlines the process of detecting safety signals and identifying potential ICSR triggers across publications, enabling teams to accelerate the filing of crucial reports such as ICSRs, MDRs, PSURs, and PERs. By optimizing post-market safety surveillance, Sorcero Safety empowers teams to more rapidly identify and report on safety issues, ultimately ensuring the well-being of patients.

Powering this platform, Sorcero Safety integrates cutting-edge, medically-tuned AI and safety classifiers with real-time updates from top sources like Medline before efficiently organizing, structuring, and tagging articles. This allows pharmaceutical and medical device teams to quickly search, filter, and analyze the ever-expanding body of published literature.

• Leveraging advanced AI classifiers, Sorcero Safety achieves 90% greater accuracy in detecting ICSR-triggering literature.
• Sorcero Safety identified 272% more relevant safety content than their existing method. This includes a 1,046% increase in detecting unique safety content, and 200% more ICSRs, helping the team identify safety data and cases they would have otherwise missed.
  
  
  

Benefits

• Access the most comprehensive literature database for unparalleled coverage
  • Sorcero's partnership with Springer Nature provides the world's most extensive literature database, significantly reducing the risk of missing critical safety information
• Rapidly identify safety signals across the large body of published literature
  • Sorcero Safety’s centralized literature dashboard provides instant access to organized, structured, and deduplicated publications, and powerful dashboards display safety trends over time for deeper analysis
• Achieve greater accuracy in PMS and detecting literature likely to trigger an ICSR
  • Best-in-class ICSR and non-ICSR classifiers flag relevant publications, and AI-powered tagging and filtering identify safety signals associated with a specific product area
• Comply with ICSR and literature monitoring requirements
  • The dedicated, GxP-validated tenant maintains security of sensitive healthcare data, and advanced ontologies align with ICSR, IVDR, and MDR regulations
    
    

Learn more about this new offering from Sorcero and Springer Nature here.

5 New Intelligent Medical  Themes^TM
Instantly find information on key medical topics

The need: a better way to surface complex insights
For Medical Affairs teams, it's time-consuming and tedious to manually sift through massive amounts of records and categorize them into relevant topics such as safety, efficacy, mechanism of action and more. Doing so manually typically takes weeks to months, and as a result key content – and crucial insights – can easily slip through the cracks. 

Relying on traditional search methods falls short as well. These approaches depend heavily on exact keyword matches, which is particularly problematic in the complex world of medical language. Medical concepts often have multiple synonyms, acronyms, related terms, or use varied phrasing, making it challenging to capture all related information by searching for keywords. Like manual analysis, traditional keyword search can also lead teams to miss out on crucial data and insights. 

Solving this Challenge with Sorcero Intelligent Medical Themes
In order to help address this challenge, we developed Sorcero Intelligent Medical Themes^TM (IMTs). IMTs use advanced medically-tuned LLMs–trained specifically to understand medical language and ontologies to identify and tag records relevant to known topics of interest (such as safety and efficacy) in data sources. When tagging records, IMTs look at the entire record, not just specific words, since the context of a word or sentence can dramatically alter a record’s meaning. This approach ensures that all relevant information and insights are surfaced, even when a keyword isn’t present. 

Introducing Five New IMTs
We first introduced Sorcero IMTs for safety and efficacy, enabling teams to quickly analyze records pertaining to these key topics. This release, we're introducing five additional IMTs: Market Access, Patient Recruitment, Mechanism of Action, Evidence Gap, and General Sentiment.

Market Access tags records containing information about patient accessibility to a specific drug.

• Benefit: This IMT is crucial for identifying issues relating to pricing, distribution channels, reimbursement and more.
• Use case: Helps Health Economics and Outcomes Research (HEOR) teams develop accurate Health Technology Assessment (HTA) packages.

Patient Recruitment flags records with associated information about clinical trial recruitment.

• Benefit: With this IMT, teams can monitor the ongoing success (or challenges) of clinical trials and gauge resulting effects on recruitment efforts.
• Use case: Understand historical roadblocks to patient enrollment to solve these issues in future trials.

Mechanism of Action (MoA) identifies records associated with a drug's effect in the body. 

• Benefit: Identifying MoA is complex because it requires synthesizing diverse information sources, from a drug's chemical structure to real-world patient outcomes. With this IMT, teams can more easily develop a comprehensive view of a drug's MoA in real-world settings.
• Use case: Answer HCP questions about a drug's efficacy, at a specific point or over time.

The Evidence Gap theme flags records that highlight missing or incomplete information about a drug.

• Benefit: This helps teams better understand where to focus research efforts and identify areas needing further investigation.
• Use case: identify candidates for Investigator Initiated Trials (IITs) to address evidence gaps related to long-term efficacy for specific patient populations.

General Sentiment tags records that contain any indication of strong sentiment, regardless of the specific theme associated with that sentiment (like safety or efficacy).

• Benefit: This allows teams to quickly surface and dive deep into any content containing a strong opinion.
• Use case: Understand whether a KOL has a positive or negative sentiment towards your drug.

These new IMTs not only dramatically speed up time to find relevant records, but also significantly improve the depth of insights derived from complex medical information.

How to use these new Intelligent Medical Themes
These new IMTs are available as drop-down filters from the record labels filter in Sorcero MIM. Simply select the specific IMT to filter records by these topics. Add records to collections for further organization.

Publications in Sorcero MIM
The need: a complete view of all data sources
When developing Sorcero MIM, our vision was to create a single, collaborative platform that unifies, structures, and enriches the vast array of internal data sources pertinent to medical teams – from field notes and advisory board transcripts to CRMs and surveys.

MIM has successfully enabled teams to instantly find evidence and uncover new insights about their customers, products, and patients from internal sources. With MIM, Medical Affairs teams have unlocked 300% more insights from medical data, including from unstructured sources like HCP notes and presentations.

But company data tells only part of the story. Teams can also glean significant insights from external sources, particularly in published literature. To achieve a truly comprehensive, 360-degree view of medical evidence, teams must incorporate these external publications into their insights discovery process. Without these data sources in one place, teams are forced to manually combine and analyze information manually. Not only slow and tedious, this process severely hampers the ability to connect insights and uncover deeper trends across different sources, such as the why behind the what, relationships between medical activities and their impact, and predictive events.

Bringing publication information into Sorcero MIM
To address this challenge, publication information is now available in Sorcero MIM, enabling teams to instantly find insights across all internal and external sources. This publication information leverages Sorcero IPM, the publication analytics dashboard, which combines, organizes, and structures over 250M+ publications from 20+ sources. 

By integrating publication data directly into MIM, teams can now uncover more comprehensive insights across a wider swath of information and understand internal data in the context of product, market, and competitive trends in published literature.

• Use the latest scientific knowledge to guide drug development, marketing, and Medical Affairs activities
• Maintain informed engagement with healthcare professionals, researchers, and regulatory bodies based on internal and external data sources
• Track competitive activities like research, drug development, and clinical trials, and using this information to inform internal strategies, decision-making, priorities, and customer education

• Faster time to insights: Leverage the Instant Insights Engine to generate comprehensive insights across both internal and external sources rapidly, allowing you to more quickly determine who to engage, where, how and with what content.
• Greater visibility: Access a centralized, structured dashboard that combines company data and publication literature in one place for performance tracking, insights dissemination and impact KPIs.
• More informed decision making: Guide and define patient-centric strategic priorities based on a robust volume of insights from diverse sources.